↓ Skip to main content

Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults

Overview of attention for article published in this source, June 2013
Altmetric Badge

Mentioned by

blogs
2 blogs
policy
1 policy source
twitter
29 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults
Published by
John Wiley & Sons, Ltd, June 2013
DOI 10.1002/14651858.cd010609
Pubmed ID
Authors

Linde M, Mulleners WM, Chronicle EP, McCrory DC, Mattias Linde, Wim M Mulleners, Edward P Chronicle, Douglas C McCrory

Abstract

Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane review first published in 2004, and previously updated (conclusions not changed) in 2007.

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Denmark 2 2%
Korea, Republic of 1 <1%
Netherlands 1 <1%
Unknown 114 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 31 26%
Student > Ph. D. Student 21 17%
Researcher 14 12%
Student > Bachelor 11 9%
Unspecified 9 7%
Other 35 29%
Readers by discipline Count As %
Medicine and Dentistry 65 54%
Unspecified 11 9%
Nursing and Health Professions 8 7%
Neuroscience 7 6%
Psychology 6 5%
Other 24 20%